Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01429389 · ClinicalTrials.gov registry record

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

A clinical trial of Down Syndrome and Fetal Aneuploidy, sponsored by Sequenom.

Recruiting
Registry status
2,000
Enrollment target
14
Study locations

NCT01429389 is a study of Down Syndrome and Fetal Aneuploidy that is actively recruiting participants, run by Sequenom. The registered enrollment target is 2,000 participants, below the 2,435-participant average among 54 other Down Syndrome trials with a reported enrollment target (18% lower). The trial reports 14 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01429389, a study of Down Syndrome and Fetal Aneuploidy, is actively recruiting participants, sponsored by Sequenom.

RECRUITING
Registry status
2,000 participants
Enrollment target
14
Study locations

Study Summary

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

Conditions Studied

Down Syndrome Fetal Aneuploidy

Study Locations (14)

California

  • Cedars-Sinai Medical Center - Los Angeles
  • Sharp-Rees Stealy Medical Group - San Diego
  • UCSD - San Diego
  • Women's Health Care Research - San Diego
  • Specialty Obstetrics of San Diego - San Diego

Michigan

  • Henry Ford Hospital - Detroit
  • Spectrum Health - Grand Rapids

Alabama

  • University of Alabama Birmingham - Birmingham

Illinois

  • Reproductive Genetics Institute - Chicago

Iowa

  • University of Iowa Health Care - Iowa City

New Jersey

  • The Cooper Health System - Camden

South Carolina

  • Medical University of South Carolina - Charleston

Nova Scotia

  • IWK Health Centre - Halifax

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2011-05
Est. Completion 2026-03

Sponsor

Sequenom

26 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01429389

The ClinicalTrials.gov registry entry for NCT01429389 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,435-participant average among 54 other Down Syndrome trials with a reported enrollment target (18% lower). The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Down Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT01429389 reports 14 study locations spanning 9 distinct geographic areas - top geographies include California, Michigan, Alabama.

Frequently Asked Questions

What is clinical trial NCT01429389 about?

NCT01429389 is a clinical study titled "Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy". The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

What is the current status of trial NCT01429389?

This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2011-05. Estimated completion is 2026-03.

What conditions does trial NCT01429389 study?

This clinical trial studies the following conditions: Down Syndrome, Fetal Aneuploidy.

Who is sponsoring clinical trial NCT01429389?

This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01429389 being conducted?

This trial has 14 study locations across Alabama, California, Illinois, Iowa, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Down Syndrome

All registered trials for this condition

Fetal Aneuploidy

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.